Clinical Trials Directory

Trials / Completed

CompletedNCT04445051

Investigation of New Intermittent Catheters in Healthy Volunteers

Exploratory Investigation on Performance and Safety of New Intermittent Catheters in Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Coloplast A/S · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Investigation of non-CE marked intermittent catheters. The study was a randomized, single blinded, cross-over investigation comparing two new catheters with a comparator catheter in 30 adult healthy volunteers.

Detailed description

The CP322 study investigated a novel non-CE marked intermittent catheter for males and females, designed in two different variants, Variant 1 and Variant 2, respectively. The study was conducted in Denmark and was a randomized, single blinded, cross-over investigation comparing the two new variant catheters with a comparator catheter in 30 adult healthy volunteers. For each participant, the study thus contained three test visits/treatment arms (Comparator, Variant 1 and Variant 2, respectively), to which the 30 participants were randomized using a randomization sequence of six (i.e., there were six different random options for the order in which the participants tested the three catheters). There were 4-14 days between the test visits.

Conditions

Interventions

TypeNameDescription
DEVICESpeediCath® Standard male or femaleIntermittent catheterization through the urethra draining the bladder, using SpeediCath® Standard male or female.
DEVICENew intermittent Variant 1 catheter for male or femaleIntermittent catheterization through the urethra draining the bladder, using the new Variant 1 for male or female.
DEVICENew intermittent Variant 2 catheter for male or femaleIntermittent catheterization through the urethra draining the bladder, using the new Variant 2 for male or female.

Timeline

Start date
2020-03-01
Primary completion
2020-09-01
Completion
2020-09-01
First posted
2020-06-24
Last updated
2023-07-03
Results posted
2023-07-03

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04445051. Inclusion in this directory is not an endorsement.